Table 2 Summary of studies on appropriateness of antibiotic prescribing (according to reference guidelines)
Publication | Duration/ period of study | Location | Health care level | Study population | No. of prescriptions | Appropriate (%) | Reference guidelines | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No contra-indication/ allergy label | Indication | Drug choice | Dose | Dosing frequency | Duration | Administration route | Overall appropriate use | |||||||
Enriquez et al. [56] | November to December 2017 | Liberia | – | Patients undergoing a surgical procedure | 143 | – | – | – | – | – | – | – | 20.3% | CDC wound guidelines |
BSumaila and Tabong. [80] | 1st of January, 2009 and 31st December, 2014 | Ghana | Secondary | Outpatient children with URTIs on antibiotics | 237 | – | – | – | 93.0% | 95.6% | 96.7 | – | – | STG and GNDP |
Ankrah et al. [46] | 19–21 June 2019 | Ghana | Tertiary | Patients on any antibiotics admitted before 8am in all wards on the survey day | 967 | – | – | – | – | – | – | – | 89.0% | GNDP and KBTHDOG |
Sefah, Sneddon et al. [76] | January to December 2020 | Ghana | Secondary | Dental care patients | 1269 | – | – | – | – | – | – | – | 87.5% | STG |
Sefah, Denoo et al. [75] | January to May 2021 | Ghana | Tertiary | patients undergoing surgery; Surgical antimicrobial prophylaxis | 597 | – | – | 67.0% | – | – | 8.7% | – | 2.5% | STG |
Hope et al. [57] | 1 January to 31 December 2021 | Ghana | Patients with acute conjunctivitis | 111 | – | – | – | – | – | – | – | 71.2% | STG | |
Aboderin et al. [34] | 10–27 June 2019 | Nigeria | Mixed; Tertiary and secondary | in-patients including neonates | 321 | – | – | – | – | – | – | – | 39.4% | Unspecified guidline |
Agyare et al. [42] | 10th and 17th of December 2019 | Ghana | Tertiary | in-patients | 82 | – | – | – | – | – | – | – | 25% | Unspecified guidline |
Kamara et al. [58] | July -August 2021 | Sierra leone | Mixed; Tertiary, secondary | Acute healthcare hospitals and inpatient | 883 | – | – | – | – | – | – | – | 29% | National treatment guideline |
Afriyie et al. [41] | January to June 2015 | Ghana | – | Out- and in-patient with prescribed ceftriaxone injections | 251 | 100% | 86.9% | - | 100% | 100% | 85.7% | – | 93.0 | STG |